Collaborative Specialty Care for Gulf War Syndrome

LM
NA
NW
AL
Overseen ByAmanda L Matteson
Age: Any Age
Sex: Any
Trial Phase: Academic
Sponsor: VA Office of Research and Development
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial seeks the best way to deliver treatments to veterans with Gulf War Illness (GWI), a condition affecting many who served in the Gulf War. The study compares two approaches: specialists providing one-time advice to local doctors, and specialists working closely with veterans for ongoing care and treatment adjustments through the Collaborative Specialty Care model. It targets Gulf War veterans who struggle with GWI, experience daily pain that limits activities, and already have a primary care doctor through Veterans Affairs (VA).

As an unphased trial, this study offers veterans the chance to contribute to research that could enhance care strategies for GWI.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What prior data suggests that this model of care is safe for Gulf War Veterans with Gulf War Illness?

Research shows that the type of care being tested for Gulf War Illness has been tried in other situations and is usually well-tolerated. Veterans who received similar care experienced significant improvements and were twice as likely to have a 30% reduction in pain. This indicates that the treatment is both effective and safe for patients. Although specific information on side effects for this study is unavailable, positive results in similar cases suggest it is safe.12345

Why are researchers excited about this trial?

Researchers are excited about the trial for collaborative specialty care for Gulf War Syndrome because it offers a fresh approach to treatment. Unlike traditional methods that often involve separate management of symptoms, this approach integrates health coaching and problem-solving treatment directly into the care plan, with ongoing optimization of pain management strategies. This collaborative model aims to improve coordination between specialists and primary care providers, potentially leading to more personalized and effective care for veterans. By focusing on comprehensive care and regular adjustments, this strategy hopes to deliver better outcomes for those affected by this complex condition.

What evidence suggests that this trial's treatments could be effective for Gulf War Illness?

Research has shown that collaboration with specialists can improve health for Gulf War Veterans with Gulf War Illness (GWI). In this trial, participants will join one of two treatment arms. The collaborative specialty care arm addresses the gap in treatment advice by offering health coaching and problem-solving support, helping veterans manage symptoms and use pain relief medication more effectively. Meanwhile, the e-consultation arm provides a one-time recommendation from the specialty provider team to the primary care team for local health coaching and analgesic optimization. Both approaches may lead to more personalized and effective care, potentially enhancing satisfaction and health outcomes for veterans with GWI.46789

Who Is on the Research Team?

LM

Lisa Marie McAndrew, PhD

Principal Investigator

East Orange Campus of the VA New Jersey Health Care System, East Orange, NJ

SE

Scott E. Sherman, MD MPH

Principal Investigator

VA NY Harbor Healthcare System, New York, NY

JK

Justeen K Hyde, PhD

Principal Investigator

VA Bedford HealthCare System, Bedford, MA

Are You a Good Fit for This Trial?

This trial is for Gulf War Veterans who served in Operation Desert Shield/Storm and meet the Kansas City (Steele) definition of Gulf War Illness. They should experience pain that limits their activities, rating at least a 3 out of 10 on a pain scale, and must have a VA primary care provider. Those with suicidal intent or previous specialized evaluations or participation in related trials are excluded.

Inclusion Criteria

My pain limits my activities at a level of 3 or more on a scale of 0 to 10.
Deployed to Operation Desert Shield/Storm
Meets Kansas City (Steele) definition of GWI (which excludes conditions that may account for GWI)
See 1 more

Exclusion Criteria

Suicidal intent
Previous evaluation at the WRIISC or participated in our clinical trial for GWVs with GWI

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive health coaching and problem-solving treatment, with monthly optimization of analgesics in collaborative specialty care or a onetime recommendation in e-consultation

9 months

Follow-up

Participants are monitored for safety and effectiveness after treatment

4-8 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Collaborative Specialty Care
  • e-consultation
Trial Overview The study is testing Collaborative Specialty Care versus standard care to improve treatment delivery for veterans with Gulf War Illness. It will use e-consultation methods to see if this improves satisfaction and health outcomes compared to current practices within the VA system.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: collaborative specialty careExperimental Treatment1 Intervention
Group II: e-consultationActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

VA Office of Research and Development

Lead Sponsor

Trials
1,691
Recruited
3,759,000+

Published Research Related to This Trial

The Partnership Study explored the effectiveness of video consultations involving patients, general practitioners (GPs), and oncologists, revealing that while the concept is seen as useful, addressing technical and organizational challenges is crucial for successful implementation.
Interviews with oncologists highlighted the need for better structuring of consultations and communication, as well as careful case selection to enhance the collaborative care model between GPs and oncologists in cancer treatment.
Cross-sectoral communication by bringing together patient with cancer, general practitioner and oncologist in a video-based consultation: a qualitative study of oncologists' and nurse specialists' perspectives.Hansen, DG., Trabjerg, TB., Sisler, JJ., et al.[2021]
The collaborative care model, which included a one-time consultation with a sleep specialist, significantly improved provider adherence to sleep-focused interventions, with referrals for polysomnography increasing from 6% to 49%.
Patients receiving the intervention reported better sleep outcomes, including a reduction in total wake time and improved sleep efficiency, with 41% showing significant improvement on the Pittsburgh Sleep Quality Index compared to 21% in the control group.
A Collaborative Paradigm for Improving Management of Sleep Disorders in Primary Care: A Randomized Clinical Trial.Edinger, JD., Grubber, J., Ulmer, C., et al.[2018]
The study is evaluating the effectiveness and implementation of the Collaborative Behavioral Health Program (CBHP) in 11 primary care practices over a 30-month period, aiming to improve access to mental health services for depression.
It will provide insights into the barriers and facilitators of implementing the Collaborative Care Model (CoCM) and conduct economic analyses to assess the cost-effectiveness of the program, potentially benefiting both mental health outcomes and chronic health conditions.
Collaborative care for depression management in primary care: A randomized roll-out trial using a type 2 hybrid effectiveness-implementation design.Smith, JD., Fu, E., Rado, J., et al.[2022]

Citations

RePORT RePORTER - National Institutes of Health (NIH) |Protocol for a type 1 hybrid effectiveness/implementation clinical trial of collaborative specialty care for Veterans with Gulf War Illness. ; Life sciences2022 ...
Collaborative Specialty Care for Gulf War IllnessThe investigators' data show 70% of GWVs with Gulf War Illness (GWI) do not receive treatment recommendations for their GWI and 78% are NOT very satisfied with ...
IIR 19-469 – HSR Study - VA Health Systems ResearchOur data show 70% of GWVs with Gulf War Illness (GWI) do not receive treatment recommendations for their GWI and 78% are NOT very satisfied with their care. ...
Collaborative Specialty Care for Gulf War SyndromeThe investigators' data show 70% of GWVs with Gulf War Illness (GWI) do not receive treatment recommendations for their GWI and 78% are NOT very satisfied with ...
Protocol for a type 1 hybrid effectiveness/implementation ...Protocol for a type 1 hybrid effectiveness/implementation clinical trial of collaborative specialty care for Veterans with Gulf War Illness.
Collaborative Specialty Care for Gulf War IllnessThe investigators' data show 70% of GWVs with Gulf War Illness (GWI) do not receive treatment recommendations for their GWI and 78% are NOT very satisfied with ...
Collaborative Specialty Care for Gulf War IllnessOur data show 70% of GWVs with Gulf War Illness (GWI) do not receive treatment recommendations for their GWI and 78% are NOT very satisfied with their care. ...
Collaborative Specialty Care for Gulf War IllnessFunded Project Details - FY2025 ; Title: Collaborative Specialty Care for Gulf War Illness ; Principal Investigator: Lisa McAndrew ; Location: East ...
Protocol for a type 1 hybrid effectiveness/implementation ...Veterans receiving the collaborative specialty care-like intervention were twice as likely to have a 30% improvement in pain and showed ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security